tiprankstipranks
Trending News
More News >
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
US Market

Knight Therapeutics (KHTRF) Income Statement

Compare
32 Followers

Knight Therapeutics Income Statement

Last quarter (Q3 2025), Knight Therapeutics's total revenue was C$121.55M, an increase of 31.74% from the same quarter last year. In Q3, Knight Therapeutics's net income was C$-3.79M. See Knight Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 371.30MC$ 328.20MC$ 293.56MC$ 243.48MC$ 199.52M
Gross Profit
C$ 174.41MC$ 152.65MC$ 138.06MC$ 115.41MC$ 81.69M
Operating Expenses
C$ 167.01MC$ 155.54MC$ 155.12MC$ 128.24MC$ 111.69M
Depreciation and Amortization
C$ 53.11MC$ 50.40MC$ 62.62MC$ 47.91MC$ 32.08M
EBITDA
C$ 64.38MC$ 40.90MC$ 25.26MC$ 42.59MC$ 67.56M
Operating Income
C$ 7.40MC$ -2.89MC$ -2.40MC$ -5.32MC$ -3.44M
Other Income/Expenses
C$ -5.34MC$ -19.10MC$ -2.92MC$ 19.52MC$ 62.74M
Pretax Income
C$ 2.05MC$ -21.99MC$ -43.96MC$ 6.69MC$ 32.09M
Net Income
C$ 4.33MC$ -16.84MC$ -29.89MC$ 15.68MC$ 31.76M
Per Share Metrics
Basic EPS
C$ 0.04C$ -0.16C$ -0.26C$ 0.13C$ 0.24
Diluted EPS
C$ 0.04C$ -0.16C$ -0.26C$ 0.13C$ 0.24
Weighted Average Shares Outstanding
101.04M 107.47M 114.89M 124.48M 131.78M
Weighted Average Shares Outstanding (Diluted)
101.44M 107.47M 114.89M 124.52M 131.99M
Currency in CAD

Knight Therapeutics Earnings and Revenue History